Robert Carr is a career entrepreneur focused on better use of human intellectual capital. After identifying computational neuropharmacology as the opportunity for such development in the pharmaceutical industry, Mr. Carr began successfully organizing and developing In Silico Biosciences, Inc. in 1999.
Mr. Carr has a BS in mathematics from the University of California, Riverside, and an MBA from Harvard.
Athan Spiros began working in mathematical biology in 1989. He now contributes more than 20 years of advanced neuromodeling experience, first in neuroinflammation and later in information processing in complex brain circuits.
Dr. Spiros has a bachelor’s of science degree in mathematics from California Polytechnic State University San Luis Obispo, a master’s degree from SUNY at Stony Brook and a doctorate in applied mathematics from the University of British Columbia where he worked under renowned mathematical biologist Leah Edelstein-Keshet.
Petri Takkala’s education and relevant training in neuroscience, medical biophysics, and the study of pain inform his work in ISB’s development of a platform to optimize effective combination pharmacotherapy for chronic pain relief.
Dr. Takkala has a bachelor’s and master’s of science in neurosciences from the University of Toronto, where he also was awarded a doctorate in medical science/neuroscience.
Hugo Geerts has extensive professional experience in drug research, discovery, and development supported by leadership in computer-based mechanistic models of the brain with a particular focus on central nervous system disorders and chronic pain management.
Dr. Geerts completed his undergraduate degree in theoretical physics and a doctorate in biophysics and medical studies from the University of Antwerp, as well an Executive Pharmaceutical MBA from Drexel University’s LeBow Business College.
David Guydan is an experienced business executive/entrepreneur who has directed for-profit and nonprofit ventures across the complete range of organizational functions, creating new businesses, achieving business turnarounds and sustained growth.
Mr. Guydan has a BA in Economics from the University of Pittsburgh and an MBA from Harvard.
